Neocis

Executive Summary

Neocis is a Miami-based medical device company founded in 2012 that is revolutionizing dental implant surgery with its robotic system, Yomi. Yomi is the first and only FDA-cleared dental robotic surgical system, providing haptic guidance and computer-assisted navigation to enhance precision, efficiency, and predictability in implant placement. By integrating with existing digital workflows, Yomi allows clinicians to plan procedures virtually and execute them with real-time feedback, reducing variability and improving patient outcomes. The system addresses key challenges in implant dentistry, including limited visualization and manual dexterity constraints, making it a powerful tool for both specialized oral surgeons and general dentists expanding their implant offerings. With a strong foothold in the U.S. market and growing adoption among dental professionals, Neocis is well-positioned to capitalize on the increasing demand for digital dentistry and robotics. The company continues to iterate on its technology, with potential applications beyond implants, such as guided bone grafting and full-arch rehabilitation. As awareness of robotic-assisted dentistry rises and competition remains limited, Neocis has a clear runway for growth. Key upcoming catalysts include new product indications, international regulatory approvals, and strategic partnerships that could accelerate adoption and drive revenue expansion.

Upcoming Catalysts (preview)

• Q3 2026FDA Clearance for Expanded Indications (e.g., Full-Arch or Bone Grafting)80% success
• Q1 2027CE Mark Approval for European Market Entry60% success
• Q2 2026Strategic Partnership with Major Dental Distributor (e.g., Henry Schein or Patterson)70% success